Research findings have shown that the stimulation of i NKT cells by liraglutide is correlated with the triggering of fibroblast growth factor 21 (FGF21) synthesis, which subsequently results in weight loss [163]
However, its worth pointing out that these findings are based on patient populations who either had obesity, were overweight and had one or more weight-related conditions, and/or had type 2 diabetes
This was significantly more than the placebo group, which only lost an average of 2.4% of their body weight
in Textbook of Gastroenterology Vol
After propensity score matching, 171,105 patients were included in each group
Over a few weeks the pattern becomes readable: which days after a shot feel rough, what a dose change did, and what helped